As digestive symptoms remain the best-known reaction to GLP-1 drugs, patients and researchers are reporting possible effects on hair and nails , while sudden vision changes require urgent medical attention.
GLP-1 medicines have become central to treatment for type 2 diabetes and, in some cases, weight management, but the picture of their side effects continues to evolve. Baton Rouge General says questions from patients are increasingly shifting beyond the better-known digestive complaints to changes in hair, nails and vision.
According to Yale Medicine, common reactions to GLP-1 drugs include nausea, constipation, diarrhoea, vomiting and heartburn, although these often improve as the body adjusts. More serious problems, while less common, can include pancreatitis, gallbladder disease, allergic reactions and injection-site issues, which is why clinicians generally advise patients to report persistent or severe symptoms.
Hair shedding is one of the side effects that often causes alarm, but experts say the drugs are not usually believed to attack hair directly. Healthline and the American Academy of Dermatology both note that rapid weight loss, lower calorie intake and nutritional shortfalls can trigger temporary shedding, a pattern known as telogen effluvium. In that context, hair loss may be a sign that weight is coming off too quickly, rather than a permanent effect of the medication itself.
Nail changes are drawing closer attention, too. The American Academy of Dermatology says some people taking GLP-1 drugs have reported brittle nails, slower nail growth and other changes, while newer reporting has highlighted nail discolouration and separation of the nail from the nail bed. A study discussed by Science Focus suggested GLP-1 users were far more likely to experience nail detachment than non-users, although the researchers said more work is needed to understand why this might happen.
The most serious concern in the Baton Rouge General feature is vision. It points to emerging research suggesting a possible link between semaglutide and a rare eye condition that can cause sudden sight loss. Because that risk is still being investigated, doctors say anyone taking a GLP-1 drug who develops abrupt changes in vision should seek medical advice promptly rather than wait to see whether the problem passes.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
